Bringing Innovative Thinkers Together
When it comes to partnerships, AbbVie’s point of view is simple: They tip the balance in favor of success for patients. Whether it’s bolstering smaller biotechs, teaming up with universities or joining forces with other pharma companies around the world, partnerships are a powerful path to scientific discovery.
This approach is even more critical in 2020 and beyond, as AbbVie partnerships grow in scope and depth and align with global needs like COVID-19 potential treatments.
“AbbVie has always leveraged partnerships to remain creative, nimble and innovative as we develop therapies that target unmet needs around the world,” says Tom Hudson, M.D., senior vice president of research and development and chief scientific officer at AbbVie. “Partnerships leverage the best minds at AbbVie with the best minds outside our walls. It’s a powerful way to move science forward for patients.”
With the recent acquisition of Allergan, AbbVie has allocated significant funding for additional business development. The company continues to pursue strategic opportunities that fit within key focus areas.